Cholesterol-Based Nanovesicles Enhance the In Vitro Cytotoxicity, Ex Vivo Intestinal Absorption, and In Vivo Bioavailability of Flutamide

Critical adverse effects and frequent administration, three times per day, limit the use of flutamide (FLT) as a chemotherapeutic agent in the treatment of prostate cancer. Therefore, our research aimed to develop new cholesterol-based nanovesicles for delivering FLT to malignant cells in an endeavo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Mohamed A., Mohamed, Magdy I., Megahed, Mohamed A., Abdelghany, Tamer M., El-Say, Khalid M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623090/
https://www.ncbi.nlm.nih.gov/pubmed/34834155
http://dx.doi.org/10.3390/pharmaceutics13111741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623090/
https://www.ncbi.nlm.nih.gov/pubmed/34834155
http://dx.doi.org/10.3390/pharmaceutics13111741

Ejemplares similares